Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04869670 · ClinicalTrials.gov registry record · NA

A Study to Evaluate Safety and Effectiveness of G-POEM for Gastroparesis

A NA study, sponsored by Mayo Clinic.

Terminated
Registry status
NA
Development phase
3
Enrollment target

NCT04869670: Clinical Trial NA study, sponsored by Mayo Clinic.

NCT04869670 is a NA study that was terminated before completion, run by Mayo Clinic. The registered enrollment target is 3 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT04869670, a NA study, was terminated before completion, sponsored by Mayo Clinic.

TERMINATED
Registry status
NA
Development phase
3 participants
Enrollment target

Study Summary

The purpose of this research is to evaluate the 12-month treatment effect of peroral endoscopic pyloromyotomy (G-POEM) vs. sham surgery in patients with gastroparesis that is not helped by medications and to analyze factors that may predict the outcome of the surgery.

Primary Outcome

The effect of GPOEM on nausea, early satiety, postprandial fullness, and upper abdominal pain as per changes in patient scoring in The American Neurogastroenterology and Motility Society Gastroparesis Cardinal Symptom Index Daily Diary (ANMS GCSI-DD) which has been designed to assess symptoms associated with gastroparesis. ANMS GCSI-DD evaluates five core symptoms: nausea, bloating, upper abdominal pain, stomach fullness and inability to finish a meal. Each symptom is rated 0-4 with 0= none, 1=

Interventions

  • PROCEDURE Gastric peroral endoscopic myotomy.
  • PROCEDURE Sham Gastric peroral endoscopic myotomy.

Trial Details

FieldValue
Enrollment Target 3 participants
Start Date 2023-07-12
Est. Completion 2025-03-03
Phase NA
Mayo Clinic

2,844 total trials

Why NCT04869670 stopped before completion

NCT04869670 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 3 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).

The record links to 0 conditions, and to 2 interventions - of which Gastric peroral endoscopic myotomy. is the first listed.

NCT04869670 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04869670 about?

NCT04869670 is a clinical study titled "A Study to Evaluate Safety and Effectiveness of G-POEM for Gastroparesis". The purpose of this research is to evaluate the 12-month treatment effect of peroral endoscopic pyloromyotomy (G-POEM) vs. sham surgery in patients with gastroparesis that is not helped by medications and to analyze factors that may predict the outcome of the surgery.

What is the current status of trial NCT04869670?

This trial is currently terminated. It is a NA study. The enrollment target is 3 participants. The study started on 2023-07-12. Estimated completion is 2025-03-03.

What interventions are being tested in trial NCT04869670?

The interventions under investigation include: Gastric peroral endoscopic myotomy. (PROCEDURE), Sham Gastric peroral endoscopic myotomy. (PROCEDURE).

Who is sponsoring clinical trial NCT04869670?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT04869670's enrollment target sits among peer trials

3 1996th of 2000 higher than 4 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04869670, the US trial registry maintained by the National Library of Medicine. NCT04869670 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.